Large Cap / Healthcare Equipment & Services / Pharmaceuticals, Biotechnology & Life Sciences
Time to sell this biopharmaceutical innovator.

Sale Recommendation - August 2012

August 1, 2012
/ Print /
| Share More
/ Text Size+
The Turnaround Letter recommends locking in profits on this global biopharmaceutical large cap.
To view the full article, please subscribe or login.

Your Financial Security is Serious Business...

so why should you trust The Turnaround Letter?

  • Ranked as #1 Performing Newsletter for 15-Yr. Returns: Turnaround Letter's 12.7% vs. S&P's 2.7%
  • 28+ Years of Turnaround Investing Experience & Reliable Stock Market Advice
  • Diverse Monthly Stock Picks Personally Selected by George Putnam

Distressed Investing Blog

Distressed Investing Blog

Mining Value Stocks: Beginning to Dig Out?

Because the crystal ball on all of this is still pretty hazy, I am once again suggesting that you focus on the larger players with the stronger balance sheets. Many of the smaller, more leveraged miners and metals producers may not survive if commodity prices stay low for a prolonged period. Read More.

Turnaround Stock Strategies

stock market advice

stock market advice

Dividend Turnaround Stock Picks

In this MoneyShow.com "Daily Guru" feature interview,George details three key advantages of dividend-paying turnaround stocks—and names four timely value investing stock picks suitable for conservative investors looking to cash in!

 

Dividend Turnaround Stocks